@article{randrian:hal-03287294,
TITLE = {Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study},
AUTHOR = {Randrian, Violaine and Adenis, Antoine and Desrame, J{\'e}r{\^o}me and Barbier, Emilie and Di Fiore, Fr{\'e}d{\'e}ric and Li{\`e}vre, Astrid and Dahan, Laetitia and Laurent-Puig, Pierre and Mineur, Laurent and Breysacher, Gilles and Roquin, Guillaume and Louafi, Samy and Lopez, Anthony and Louvet, Christophe and Borg, Christophe and Metges, Jean Philippe and Faroux, Roger and Gaba, Lila and Manfredi, Sylvain and Tougeron, David},
URL = {https://univ-angers.hal.science/hal-03287294},
JOURNAL = {Digestive and Liver Disease},
PUBLISHER = {Elsevier},
VOLUME = {52},
NUMBER = {3},
PAGES = {347-350},
YEAR = {2020},
MONTH = Mar, DOI = {10.1016/j.dld.2019.11.014},
KEYWORDS = {Esophageal cancer ; Irinotecan ; Paclitaxel ; Squamous cell cancer},
HAL_ID = {hal-03287294},
HAL_VERSION = {v1},
}